Application
ELISA analysis of control antigen and antigen using BMPR1A antibody [4B7B2].Application
WB analysis of human BMPR1A recombinant protein using BMPR1A antibody [4B7B2].Application
WB analysis of (1) PC-3, (2) K562 and (3) mouse liver lysates using BMPR1A antibody [4B7B2].Application
WB analysis of lysates from (1) untransfected and (2) BMPR1A (a.a. 179-378)-hIgGFc transfected HEK293 cells using BMPR1A antibody [4B7B2].Application
IHC-P analysis of colon cancer tissues using BMPR1A antibody [4B7B2].Application
IHC-P analysis of kidney tissues using BMPR1A antibody [4B7B2].Application
FACS analysis of HeLa cells using BMPR1A antibody [4B7B2] (green) or a negative control (purple).| Product Name | BMPR1A antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Mouse Monoclonal Antibody [4B7B2] to BMPR1AThe bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008] |
| Immunogen | The immunogen corresponding to a region within amino acids 179 and 378 of human BMPR1A expressed in E. Coli. |
| Conjugation | Agarose |
| Modification | Acetylated |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Clone Number | 4B7B2 |
| Host Species | Mouse |
| Tested Applications | ELISAFACSICC/IFIHCIHC-PWB |
| WB:1:500~1:2000 ICC/IF:1:100~1:500 IHC:1:50~1:200 ELISA:1:5000~1:20000 FACS:1:200~1:500 |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | CD292 ALK3 ACVRLK3 SKR5 10Q23DEL |
|---|---|
| Target | BMPR1A |
| Molecular Weight(MW) | 60 kDa (note) |
Application
ELISA analysis of control antigen and antigen using BMPR1A antibody [4B7B2].
Application
WB analysis of human BMPR1A recombinant protein using BMPR1A antibody [4B7B2].
Application
WB analysis of (1) PC-3, (2) K562 and (3) mouse liver lysates using BMPR1A antibody [4B7B2].
Application
WB analysis of lysates from (1) untransfected and (2) BMPR1A (a.a. 179-378)-hIgGFc transfected HEK293 cells using BMPR1A antibody [4B7B2].
Application
IHC-P analysis of colon cancer tissues using BMPR1A antibody [4B7B2].
Application
IHC-P analysis of kidney tissues using BMPR1A antibody [4B7B2].
Application
FACS analysis of HeLa cells using BMPR1A antibody [4B7B2] (green) or a negative control (purple).| Application Notes | WB:1:500~1:2000 ICC/IF:1:100~1:500 IHC:1:50~1:200 ELISA:1:5000~1:20000 FACS:1:200~1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | 4°C; -20°C for long term storage |
| Storage Buffer | Ascitic fluid containing 0.03% sodium azide. |
